Raised status of domestic anticancer drugs
‘Supect(radotinib)’ developed by Ilyang Pharmaceutical emerged in the leukemia treatment market which used to be occupied only by multinational companies. Anticancer treatments are no longer multinational companies’ exclusive products.
Although a SK Chemicals’ stomach cancer treatment, ‘Sunpla I...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
